Madison Wis. Third Wave Technologies Inc. reported a loss of $4.4 million on revenues of $7.1 million for the quarter that ended March 31 attributing the shortfall to the timing of large orders and slow sales of a line of reagents. Third Wave makes clinical molecular diagnostic products including reagents for the study of infectious diseases and